Abstract
A number of new tranquillizing drugs have recently become available. We report a method of assessment for one of these—“Pacatal”. In this experiment the new drug was compared with (i) no treatment at all, (ii) treatment using dummy tablets of the same size and appearance as the Pacatal tablets, and (iii) Largactil. A group of patients suffering from schizophrenia were selected, all being deteriorated. These patients can be found in considerable numbers with a reasonably similar clinical picture which is relatively stationary without treatment.
Publisher
Royal College of Psychiatrists
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2014-01-06
2. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2007-04-18
3. Chlorpromazine versus placebo for schizophrenia;Cochrane Database of Systematic Reviews;2003-04-22
4. Phenothiazine Bibliographies;Psychopharmacological Agents;1967
5. Phenothiazine und Azaphenothiazine als Heilmittel;Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques;1963